These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 1015115

  • 1. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [Abstract] [Full Text] [Related]

  • 2. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
    Kadykov AS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(2):174-8. PubMed ID: 944514
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973 Dec; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 5. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB, Vainshtok AB, Oleinik LI.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Dec; 73(4):524-30. PubMed ID: 4705407
    [No Abstract] [Full Text] [Related]

  • 6. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM, Zlydnikov DM, Mazhinskaia VP, Lebedeva VK, Zakharova NG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973 Dec; 73(4):530-4. PubMed ID: 4705408
    [No Abstract] [Full Text] [Related]

  • 7. [Combined treatment of parkinsonism with L-dopa and Parkopan].
    Lukasiewicz K.
    Wiad Lek; 1977 May 15; 30(10):775-7. PubMed ID: 867994
    [No Abstract] [Full Text] [Related]

  • 8. [Experience with the use of parlodel in the treatment of Parkinson patients].
    Stoliarova LG, Kadykov AS, Shvedkov VV, Pivovarova VM.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 May 15; 86(2):219-22. PubMed ID: 3705825
    [Abstract] [Full Text] [Related]

  • 9. [Correlation of clinico-physiologic indices and the serotonin content of the blood of patients with parkinsonism].
    Karimova MKh, Petelin LS, Aleuov ShA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988 May 15; 88(10):50-2. PubMed ID: 3213330
    [Abstract] [Full Text] [Related]

  • 10. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI, Iadgarov IS.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep 15; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract] [Full Text] [Related]

  • 11. "Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
    Caraceni T, Giovannini P, Girotti F, Parati E, Pederzoli M, Scigliano G.
    Ital J Neurol Sci; 1981 Dec 15; 2(4):337-42. PubMed ID: 7333824
    [Abstract] [Full Text] [Related]

  • 12. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM, Baroni A.
    Minerva Med; 1971 Oct 31; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract] [Full Text] [Related]

  • 13. [The antiparkinson activity of gludantan (preliminary report)].
    Kamianov IM, Andrezinia RA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1975 Oct 31; 75(6):910-6. PubMed ID: 1217399
    [Abstract] [Full Text] [Related]

  • 14. [Changes in lipid metabolism in patients with Parkinson disease after combined treatment with L-deprenil (iumex) and antiparkinson drugs].
    Alimov IIu, Nazhmidinova MN, Ganiev KhG.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Oct 31; 90(12):35-8. PubMed ID: 1965367
    [Abstract] [Full Text] [Related]

  • 15. [Difficulties and errors in ambulatory therapy of Parkinson disease].
    Braunschweiger-Brixel EM, Finck GA, Schiffter R.
    Z Gerontol; 1991 Oct 31; 24(1):39-44. PubMed ID: 2038889
    [Abstract] [Full Text] [Related]

  • 16. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 Oct 31; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Use of the preparation L-dopa in parkinsonism].
    Proniv DI, Sirotina OS, Bukhovtsev PP, Mis'kiv IaI.
    Vrach Delo; 1976 Jan 31; (1):113-6. PubMed ID: 1246837
    [No Abstract] [Full Text] [Related]

  • 19. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.
    Parkes JD, Baxter RC, Marsden CD, Rees JE.
    J Neurol Neurosurg Psychiatry; 1974 Apr 31; 37(4):422-6. PubMed ID: 4838913
    [Abstract] [Full Text] [Related]

  • 20. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F, Baroni A, Roveyaz L.
    Sist Nerv; 1970 Apr 31; 22(2):74-81. PubMed ID: 5504560
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.